State of the Art Management of Mechanical Heart Valves During Pregnancy.
Review published in Current treatment options in cardiovascular medicine (2018)
Abstract
PURPOSE OF THE REVIEW: To review the management of women with mechanical heart valves during pregnancy, from preconception counseling through delivery with a summary of the latest guidelines. RECENT FINDINGS: The hypercoagulability of pregnancy combined with the imperfect choices of anticoagulant agents contribute to a high risk of complications in pregnant women with mechanical heart valves. Valve thrombosis remains a major concern, much of which occurs during the first trimester transition to heparin-based products. The safest method of anticoagulation, with the best balance of maternal and fetal risk, is use of low-dose vitamin K antagonists, but only if therapeutic anticoagulation can be achieved with warfarin doses of ≤ 5 mg/day. Management of mechanical heart valves in pregnancy remains fraught with difficult decisions involving balancing of maternal and fetal risks as well as a high risk of maternal and fetal complications. Preconception counseling and planning is imperative. A risk-benefit discussion with the patient will help guide the choice of anticoagulation and outline the plan for safe delivery options. A multidisciplinary approach to management is advisable with close follow-up and care in a tertiary center.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Summary
To review the management of women with mechanical heart valves during pregnancy, from preconception counseling through delivery with a summary of the latest guidelines. The hypercoagulability of pregnancy combined with the imperfect choices of anticoagulant agents contribute to a high risk of...
Why This Matters for Hirudotherapy
This review article examined the state-of-the-art management strategies for pregnant women with mechanical heart valves, focusing on the delicate balance of maternal and fetal risks associated with anticoagulant therapies like heparin and vitamin K antagonists. For the American Society of Hirudotherapy, this text highlights the extreme clinical challenges of systemic thrombosis and hypercoagulability during pregnancy. While hirudotherapy is not indicated systemically for mechanical heart valves, understanding the complications of systemic anticoagulants contextualizes the localized nature of leech-derived anticoagulants like hirudin. However, the study's scope is strictly limited to conventional pharmacological management, and there is no mention of leeches, hirudotherapy, or the leech secretome in the abstract.
Citation
State of the Art Management of Mechanical Heart Valves During Pregnancy.
Aggarwal et al. · Current treatment options in cardiovascular medicine, 2018
Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026